Pfizer intends to sell its remaining residual shareholding in Haleon through a share placing, Citigroup said Tuesday. According to the release, the U.S. drugmaker will sell 662 million shares to ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Slowing demand for cold and cough medicines after the pandemic has weighed on consumer healthcare companies, and Haleon is working on clearing stocks of those products which typically sell more in ...

(RTTNews) - Pfizer Inc. (PFE) announced the sales of around 618 million ordinary shares in Haleon plc (HLN) at a price of 385 pence or about $5.01 per Ordinary Share for gross proceeds of ...

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each.